International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8252993
Original Article
Study of Demographic Profile and Risk Factors for Cataract in Young Adults at a Tertiary Care Hospital
 ,
Published
Aug. 15, 2023
Abstract

Objective: To study the demographic profile and risk factors for cataract in young adults

Materials and methods: It’s a cross sectional observational study conducted between 2021-2022 at a tertiary health care centre.100 patients with cataract between age of 20-45 years were selected. Risk factors like diabetes, field work (exposure to sunlight), high myopia, smoking were noted. Morphological type of cataract was determined with slit lamp examination.

Results: Out of 100 patients there were 49males (mean age of 38) and 51 females (mean age of 36), most of them had unilateral cataract(73%).53 % of patients had idiopathic cataract where no risk factors were identified, among identifiable risk factors field work was the strongest risk factor(11%) followed by diabetes and smoking. Posteriorsubcapsular cataract was the most common type of cataract (51%).

Conclusion: In majority of patients risk factor for cataract was found to be idiopathic, field work or excessive sunlight exposure was the strongest identifiable risk factor for cataractogenesis in young adults followed by diabetes and smoking, and posterior subcapsular cataract was the most common type of cataract at presentation

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
321 Views
213 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved